Stephen R. Davis
2021
Compensation breakdown
| Non-Equity Incentive Plan | $196,654 |
|---|---|
| Option Awards | $4,403,433 |
| Salary | $792,831 |
| Stock Awards | $4,355,433 |
| Other | $44,937 |
| Total | $9,793,289 |
Davis received $4.4M in option awards, accounting for 45% of the total pay in 2021.
Davis also received $196.7K in non-equity incentive plan, $792.8K in salary, $4.4M in stock awards and $44.9K in other compensation.
Rankings
In 2021, Stephen R. Davis' compensation ranked 1,071st out of 12,415 executives tracked by ExecPay. In other words, Davis earned more than 91.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,071 out of 12,415 | 91st |
Division Manufacturing | 365 out of 5,505 | 93rd |
Major group Chemicals And Allied Products | 129 out of 2,375 | 95th |
Industry group Drugs | 109 out of 2,096 | 95th |
Industry Pharmaceutical Preparations | 74 out of 1,546 | 95th |
Pay ratio
| Stephen R. Davis' Pay | $9,793,289 |
|---|---|
| Median Employee's Pay | $219,387 |
| Pay Ratio | 45to 1 |
In 2021, the annual total compensation of Stephen R. Davis was $9,793,289.
The annual total compensation of the median employee at ACADIA Pharmaceuticals was $219,387.
The ratio of Stephen R. Davis' pay to the pay of median employee was therefore 45 to one.
Davis' colleagues
We found five more compensation records of executives who worked with Stephen R. Davis at ACADIA Pharmaceuticals in 2021.
2021
Srdjan Stankovic
ACADIA Pharmaceuticals
President
2021
Mark Schneyer
ACADIA Pharmaceuticals
Chief Financial Officer
2021
Brendan Teehan
ACADIA Pharmaceuticals
Chief Operating Officer
2021
Elena Ridloff
ACADIA Pharmaceuticals
Chief Financial Officer
2021
Austin Kim
ACADIA Pharmaceuticals